Skip to content
OpenCapital
Get started

Entera Bio ENTX Q1 2026 earnings

Reported May 8, 2026 · After market close

EPS-$0.07Beat by $0.01
EPS estimate-$0.08

Next report

Aug 14, 2026 (In 2 weeks)
EPS estimate-$0.08

Versus estimates

Revenue

Q1 2025$42.0KQ4 2024$82.0KBeat by $42.0K

Diluted EPS

Q1 2026-$0.07Beat by $0.01
Q4 2025-$0.07Beat by $0.02Q3 2025-$0.07Beat by $0.02Q2 2025-$0.06Beat by $0.05Q1 2025-$0.06Beat by $0.01Q4 2024-$0.06Beat by $0.02

Ask the moment Entera Bio reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Entera Bio report Q1 2026 earnings?
Entera Bio (ENTX) reported Q1 2026 earnings on May 8, 2026 after market close.
What were Entera Bio's Q1 2026 revenue and EPS?
Entera Bio reported eps of $-0.07 for Q1 2026.
Did Entera Bio beat estimates in Q1 2026?
EPS beat the consensus estimate of $-0.08 by $0.01.
How did Entera Bio's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 16.7% from $-0.06.
Where can I find Entera Bio's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001178913-26-002455) and the 10-Q periodic report (0001178913-26-002458) directly on SEC EDGAR. The filing index links above go to sec.gov.